SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-341305
Filing Date
2021-11-26
Accepted
2021-11-26 17:20:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d253182d424b5.htm 424B5 365766
2 GRAPHIC g253182g02a55.jpg GRAPHIC 35269
3 GRAPHIC g253182g10s57.jpg GRAPHIC 61094
  Complete submission text file 0001193125-21-341305.txt   495589
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-253731 | Film No.: 211452287
SIC: 2836 Biological Products, (No Diagnostic Substances)